CLINICAL RESEARCH: HEART RHYTHM DISORDER
Neural Control of Heart Rate Is an Arrhythmia Risk Modifier in Long QT Syndrome
Peter J. Schwartz, MD, FACC*, , ,||,**, ,*,
Emilio Vanoli, MD*,¶,
Lia Crotti, MD, PhD*, , ,
Carla Spazzolini, DVM*,
Chiara Ferrandi, BSc ,
Althea Goosen, BSc**,
Paula Hedley, MSc ,
Marshall Heradien, MD**,
Sara Bacchini, MD*, ,
Annalisa Turco, MD*, ,
Maria Teresa La Rovere, MD#,
Antonella Bartoli, PharmD ,
Alfred L. George, Jr, MD and
Paul A. Brink, MD**
* Section of Cardiology, Department of Lung, Blood and Heart, University of Pavia, Pavia, Italy
Department of Cardiology, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy
Molecular Cardiology Laboratory, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy
Clinical Pharmacokinetics Laboratory, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy
|| Laboratory of Cardiovascular Genetics, IRCCS Istituto Auxologico, Milan, Italy
¶ Department of Cardiology, Policlinico di Monza, Monza, Italy
# Centro Medico di Montescano, IRCCS Fondazione "Salvatore Maugeri," Montescano, Italy
** Department of Medicine, University of Stellenbosch, Stellenbosch, South Africa
 Cardiovascular Genetics Laboratory, Hatter Institute for Cardiovascular Research, Department of Medicine, University of Cape Town, Cape Town, South Africa
 US/MRC Centre for Molecular and Cellular Biology, University of Stellenbosch, Stellenbosch, South Africa
 Departments of Medicine and Pharmacology, Vanderbilt University, Nashville, Tennessee.
Manuscript received June 6, 2007;
revised manuscript received August 31, 2007,
accepted September 20, 2007.
* Reprint requests and correspondence: Dr. Peter J. Schwartz, Professor and Chairman, Department of Cardiology, IRCCS Fondazione Policlinico S. Matteo, Viale Golgi 19 - 27100 Pavia, Italy. (Email: pjqt{at}compuserve.com).
Objectives: The purpose of this study was to test the hypothesis that differences in autonomic responses might modify clinical severity in long QT syndrome type 1 (LQT1) patients, those with KCNQ1 mutations and reduced IKs, in whom the main arrhythmia trigger is sympathetic activation.
Background: Some long QT syndrome (LQTS) patients experience life-threatening cardiac arrhythmias, whereas others remain asymptomatic throughout life. This clinical heterogeneity is currently unexplained.
Methods: In a South African LQT1 founder population segregating KCNQ1-A341V, we correlated major cardiac events to resting heart rate (HR) and to baroreflex sensitivity (BRS) on and off beta-adrenergic blockers (BB).
Results: In 56 mutation carriers (MCs), mean HR was lower among asymptomatic patients (p < 0.05). Among MCs with a QT interval corrected for heart rate 500 ms, those in the lower HR tertile were less likely to have suffered prior cardiac events (odds ratio [OR] 0.19, 95% confidence interval [CI] 0.04 to 0.79, p < 0.02). The BRS was lower among asymptomatic than symptomatic MCs (11.8 ± 3.5 ms/mm Hg vs. 20.1 ± 10.9 ms/mm Hg, p < 0.05). A BRS in the lower tertile was associated with a lower probability of being symptomatic (OR 0.13, 95% CI 0.02 to 0.96, p < 0.05). A similar trend was observed during BB. The MCs in the lower tertile for both HR and BRS were less frequently symptomatic than MCs with different patterns (20% vs. 76%, p < 0.05). Subjects with either ADRA2C-Del322-325 or homozygous for ADRB1-R389, 2 polymorphisms predicting enhanced adrenergic response, were more likely to have BRS values above the upper tertile (45% vs. 8%, p < 0.05).
Conclusions: Lower resting HR and "relatively low" BRS are protective factors in KCNQ1-A341V carriers. A plausible underlying mechanism is that blunted autonomic responses prevent rapid HR changes, arrhythmogenic when IKs is reduced. These findings help understanding phenotypic heterogeneity in LQTS and identify a physiological risk modifier, which is probably genetically determined.
|
Abbreviations and Acronyms
| | BB = beta-adrenergic blockers | | BRS = baroreflex sensitivity | | CI = confidence interval | | ECG = electrocardiogram | | HR = heart rate | | IKs
= delayed rectifier potassium current (slow) | | LQT1 = long QT syndrome type 1 | | LQTS = long QT syndrome | | MC = mutation carrier | | OR = odds ratio |
|
Related Articles
-
The Congenital Long QT Syndrome: A Mask for Many Faces
- Ralph Lazzara
J. Am. Coll. Cardiol. 2008 51: 930-932.
[Full Text]
[PDF]
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 51: A31-A32.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
X. Jouven, P. J. Schwartz, S. Escolano, C. Straczek, M. Tafflet, M. Desnos, J. P. Empana, and P. Ducimetiere
Excessive heart rate increase during mild mental stress in preparation for exercise predicts sudden death in the general population
Eur. Heart J.,
July 2, 2009;
30(14):
1703 - 1710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, O. Ben-Yehuda, J. J. Bax, G. K. Feld, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, S. M. Narayan, D. J. Sahn, et al.
Highlights of the Year in JACC 2008.
J. Am. Coll. Cardiol.,
January 27, 2009;
53(4):
373 - 398.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Vincent
Genotyping Has a Minor Role in Selecting Therapy for Congenital Long-QT Syndromes at Present
Circ Arrhythm Electrophysiol,
August 1, 2008;
1(3):
227 - 233.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Lazzara
The congenital long QT syndrome: a mask for many faces.
J. Am. Coll. Cardiol.,
March 4, 2008;
51(9):
930 - 932.
[Full Text]
[PDF]
|
 |
|
|